Poltep, Kanaporn
Phadungsombat, Juthamas
Kosoltanapiwat, Nathamon
Hanboonkunupakarn, Borimas
Wiriyarat, Witthawat
Suwanpakdee, Sarin
Prompiram, Phirom
Nakayama, Emi E.
Suzuki, Keita
Iwamoto, Hisahiko
Shioda, Tatsuo
Leaungwutiwong, Pornsawan
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19fm0108003, JP19fm0108003)
Article History
Received: 2 June 2022
Revised: 3 October 2022
Accepted: 13 October 2022
First Online: 27 October 2022
Change Date: 10 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12985-023-02236-3
Declarations
:
: The protocol of this study was reviewed and approved by the Ethics Committee of the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand (TMEC 19–051). This study was exempt from patient consent since only leftover specimens were used after anonymization.
: Not applicable.
: Keita Suzuki and Hisahiko Iwamoto were employed by TANAKA Kikinzoku Kogyo, which developed and donated the immunochromatographic devices for evaluation. TANAKA Kikinzoku Kogyo had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.